This company listing is no longer active
ERFNV Stock Overview
Provides various analytical testing and laboratory services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Eurofins Scientific SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €58.98 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | 0.60 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| ERFNV | FR Life Sciences | FR Market | |
|---|---|---|---|
| 7D | 0% | -3.1% | -1.1% |
| 1Y | n/a | -5.9% | -4.8% |
Return vs Industry: Insufficient data to determine how ERFNV performed against the French Life Sciences industry.
Return vs Market: Insufficient data to determine how ERFNV performed against the French Market.
Price Volatility
| ERFNV volatility | |
|---|---|
| ERFNV Average Weekly Movement | 0% |
| Life Sciences Industry Average Movement | 7.1% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ERFNV has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ERFNV's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 61,798 | Gilles Martin | www.eurofins.com |
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics.
Eurofins Scientific SE Fundamentals Summary
| ERFNV fundamental statistics | |
|---|---|
| Market cap | €8.62b |
| Earnings (TTM) | €256.50m |
| Revenue (TTM) | €6.51b |
33.6x
P/E Ratio1.3x
P/S RatioIs ERFNV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ERFNV income statement (TTM) | |
|---|---|
| Revenue | €6.51b |
| Cost of Revenue | €5.14b |
| Gross Profit | €1.37b |
| Other Expenses | €1.12b |
| Earnings | €256.50m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jul 24, 2024
| Earnings per share (EPS) | 1.33 |
| Gross Margin | 21.10% |
| Net Profit Margin | 3.94% |
| Debt/Equity Ratio | 65.2% |
How did ERFNV perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield38%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/07/03 08:20 |
| End of Day Share Price | 2024/07/03 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Eurofins Scientific SE is covered by 35 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ankush Kathuria | AlphaValue |
| Pierre-Yves Gauthier | AlphaValue |
| Hubert D'Aillieres | Banco BPI, S.A. |